Dispelling the myth of "aggressive" antihypertensive therapy.

Journal of clinical hypertension (Greenwich, Conn.)

Volumn 8, Issue 1 Suppl 1, 2006, Pages 4-11

  Ofili, Elizabeth O ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG COMBINATION; DRUG EFFECT; HUMAN; HYPERTENSION; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; REVIEW;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CARDIOVASCULAR DISEASES; DRUG THERAPY, COMBINATION; HUMANS; HYPERTENSION; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIALS;

MLCS; MLOWN;

EID: 33646439470     PISSN: 15246175     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-6175.2005.05293.x     Document Type: Review

References (59)